NSC |
Compound |
Enrichment |
Correlation |
NSC 628682 |
Null |
0.000967118311825486 |
0.20762102 |
NSC 693117 |
Null |
0.000967118311825486 |
0.4005872 |
NSC 643006 |
Null |
0.00104257542638397 |
0.30542975 |
NSC 707909 |
Null |
0.00104257542638397 |
0.44924971 |
NSC 683048 |
Null |
0.0013187520236934 |
0.17768411 |
NSC 224131 |
N-Phosphonacetyl-L-aspartate |
0.00134664791567076 |
0.1928692 |
NSC 344505 |
5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- |
0.00134664791567076 |
0.36233174 |
NSC 106557 |
5.alpha.,25D-Spirostan-3.beta.-ol glycoside |
0.00162803849483079 |
0.20164513 |
NSC 357114 |
CS-12350 |
0.00162803849483079 |
0.029457137 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.00162803849483079 |
0.034607978 |